No Data
No Data
BrainsWay Reports Independent Pilot Data On Accelerated Deep TMS Treatment Of Alcohol Use Disorder
BrainsWay's Deep TMS Shows Promise in Pain Reduction
BrainsWay Announces The Publication Of Feasibility Clinical Data Evaluating The Analgesic Effects Of Deep Transcranial Magnetic Stimulation In Patients With Peripheral Neuropathic Pain. The Results Were Published In The Neuromodulation Journal, In A...
Ladenburg Thalmann Maintains Brainsway(BWAY.US) With Buy Rating, Raises Target Price to $13.4
BrainsWay Ltd. (BWAY) Q3 2024 Earnings Call Transcript
BrainsWay Raises FY2024 Sales Guidance to $40.00M-$41.00M VS Est. $39.86M